1. To evaluate study on effects of rituximab or cyclosporine in the treatment of membranous nephropathy.
2. To determine clinical significance of study results.
Thursday, October 3, 2019 - 1:00pm to 2:00pm
UCMC, AMB W-507
5700 S Maryland Ave
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Nevin Murthy